Synthetic Biology's Impact on the Healthcare Industry Examined in Newly Released Report
The market for synthetic biology products and technologies shows the potential to becoming one of the quickest growing areas in the life science industry.
Dublin, Ireland (PRWEB) January 25, 2006
Research and Markets (http://www. researchandmarkets. com/reports/c31391 (http://www. researchandmarkets. com/reports/c31391)) has announced the addition of Synthetic Biology, A New Paradigm For Biological Discovery to their offering.
Synthetic biology's impact on the healthcare industry is examined in a newly released report, "Synthetic Biology, A New Paradigm for Biological Discovery", which reveals the market for synthetic biology products and technologies as potentially one of the fastest growing segments of the life sciences market. Although the research market is currently $600M, the potential for growth in the next 10 years is projected to expand this market to over $3.5B. The report is based on in-depth interviews of leading scientific researchers and biotechnology executives and presents the current research and how it may be directly applied to the development of tools and systems for clinical, pharmacological and environmental applications. It also shows that new drug applications discovered through synthetic biology have streamlined the pharmaceutical industry's ability to deliver new therapeutic agents.
ABOUT SYNTHETIC BIOLOGY
What began with DNA cloning is becoming one of the most essential areas of biological research today: synthetic biology. The field of synthetic biology is comprised of experts from different fields of study, such as biochemists, molecular biologists, engineers, and organic chemists, who take existing biological pieces, transform them into micro-machines and create artificial systems that mimic the properties of living systems. By creating systems that mimic what nature has created, scientists can discover the basic principles that rule living systems, manipulate these systems, and eventually find treatments for many diseases plaguing humanity. Today's synthetic biologists are looking to channel genetic engineering from a hit-or-miss field of discovery to the type of discipline used by engineers to build bridges, computers and buildings. This approach can translate into more specific anticancer therapies and anti-viral drugs, as well as more efficient drug delivery systems that will have a significant impact on the healthcare industry.
Summary
This report defines the overall field of synthetic biology and provides a definition of synthetic biology based on the interpretations of engineers, chemists and biologists who specialize in this field. Although there are several variations on the definition of synthetic biology, there are commonalities which hold throughout and are discussed. Ongoing research from academic institutions as well as biotechnology and pharmaceutical companies are discussed at length. Discoveries and applications from the field of synthetic biology, both current and future, are detailed, and business opportunities from these applications are investigated. Biotechnology and pharmaceutical companies as well as academicians involved in synthetic biological research are mentioned, along with partnerships formed between the different industries. As much of the research begins in the laboratories of the academic institutions and then branches out to the companies that can advance and market it, this report begins with a discussion of the definition of synthetic biology.
For more information visit http://www. researchandmarkets. com/reports/c31391 (http://www. researchandmarkets. com/reports/c31391)
Laura Wood
Senior Manager
Research and Markets
Fax: +353 1 4100 980
# # #
